JAMA Oncology : Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
- Author
- American Medical Association, 2017
- Published
- Thu 24 Oct 2024
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamaoncol.2024.5129
Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.
Related Content:
